To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06336291
Title A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence (GLIOSTELLA)
Acronym GLIOSTELLA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Philogen S.p.A.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Northwestern Memorial Hospital NOT_YET_RECRUITING Chicago Illinois 60611 United States Details
Massachusetts General Hospital (MGH) NOT_YET_RECRUITING Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center (BIDMC) NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute (DFCI) RECRUITING Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Abramson Cancer Center of the University of Pennsylvania NOT_YET_RECRUITING Philadelphia Pennsylvania 19104 United States Details
UPMC Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
University of Virginia (UVA) NOT_YET_RECRUITING Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field